Research

Clinical trials are a crucial part of the healthcare landscape, helping us to improve patient outcomes and discover groundbreaking treatments. At Ramsay Clinic New Farm, we are proud to offer a wide range of clinical trials in a world-class facility, catering for patients in the heart of Brisbane.

Ramsay is proud to play a leading role in Australia’s health and medical research sector by driving research through the Ramsay Hospital Research Foundation, our Clinical Trials Network, and our Research Ethics, and Governance Unit. Our expert clinical trial team is committed to maintaining the highest standards of care, aligning with Ramsay Health’s core value of “People Caring for People.“ We offer a range of phase II and phase III trials, which are experimental therapies that have already undergone pre-clinical and dose range studies. These trials focus on evaluating effectiveness and comparing the new therapies to existing treatments before potentially being approved for use in the community.

If you’re interested in participating in a clinical trial, you may be eligible for one currently being conducted at Ramsay New Farm Clinic, as listed below. Please speak with your doctor to explore your options.

For any inquiries, please contact Dr Francois Windels, Clinical Trials and Research Manager via email at Research.NFC@ramsayhealth.com.au

For more information about Research throughout the Ramsay network, please visit Ramsay Research.

ClinTrial Refer is a digital platform to simplify access and accelerate recruitment to clinical trialsAll research activity that is to be undertaken within Ramsay Health Care has both Human Research Ethics Committee (HREC) and Research Governance approval in place.Governance applications are prepared and submitted through Ramsay Research, Ethics and Governance portal (REGGS).

Acronym Balsam 1                                                   Recruiting
Title A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Indication

Bipolar-I disorder

Registration Number

NCT06951698

Intervention

Drug - KarXT

Description

This clinical trial is for people with Bipolar Disorder – I. The purpose of this study is to see how well it works and the safety of a new drug called KarXT for the treatment of manic episodes in Bipolar-I Disorder. Participation in this clinical trial is voluntary, please consult your doctor for more information

Sponsor

Bristol-Myers Squibb